CD274 and hepatocellular carcinoma: This case suggests that an immunotherapy-based multimodal regimen integrating TACE, surgery, TKI therapy, radiotherapy, and programmed cell death protein 1 (PD-1) blockade can achieve deep and durable remission in selected patients with advanced HCC and low PD-L1 expression.